Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain

被引:55
|
作者
Quintana, E. [1 ,2 ,3 ]
Coll, C. [1 ]
Salavedra-Pont, J. [1 ]
Munoz-San Martin, M. [1 ]
Robles-Cedeno, R. [1 ,2 ,3 ]
Tomas-Roig, J. [1 ]
Buxo, M. [4 ]
Matute-Blanch, C. [5 ]
Villar, L. M. [2 ,6 ]
Montalban, X. [2 ,5 ]
Comabella, M. [2 ,5 ]
Perkal, H. [1 ]
Gich, J. [1 ,3 ]
Ramio-Torrenta, L. [1 ,2 ,3 ]
机构
[1] Dr Josep Trueta Univ Hosp, Neuroimmunol & Multiple Sclerosis Unit, Girona Biomed Res Inst, IDIBGI,Neurol Dept, Dr Castany S-N, Salt 17190, Girona, Spain
[2] REEM, Madrid, Spain
[3] Univ Girona, Fac Med, Dept Med Sci, Girona, Spain
[4] IDIBGI, Girona Biomed Res Inst, Girona, Spain
[5] Univ Autonoma Barcelona, Serv Neurol Neuroimmunol, Ctr Esclerosi Multiple Catalunya Cemcat, Inst Recerca Vall Hebron,VHIR,Hosp Univ Vall Hebr, Barcelona, Spain
[6] Hosp Ramon & Cajal, Dept Immunol, IRYCIS, Madrid, Spain
关键词
biomarkers; chitinase; 3-like; 1; mild cognitive impairment; multiple sclerosis; neurofilament light chain; MINIMAL ASSESSMENT; BIOMARKERS; TESTS; MS;
D O I
10.1111/ene.13687
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Chitinase 3-like 1 (CHI3L1) and neurofilament light chain (NF-L) are promising biomarkers of disability in multiple sclerosis (MS). However, their role in cognitive dysfunction remains elusive. Here, we aimed to correlate cerebrospinal fluid (CSF) levels of CHI3L1 and NF-L with cognitive status in MS. Methods: Fifty one recently diagnosed patients were cognitively evaluated and CSF was collected. Levels of CHI3L1 and NF-L were determined by ELISA. Spearman's partial correlation coefficient was performed. Results: After adjusting cognitive scores by age, anxiety and EDSS, association was detected between CHI3L1 levels and Trail Making Test A (rs = 0.348; p = 0.016) and between NF-L levels and Word List Generation (rs = -0.324; p = 0.025). Conclusion: High levels of CSF CHI3L1 and NF-L are associated with cognitive impairment in the early phases of MS.
引用
收藏
页码:1189 / 1191
页数:3
相关论文
共 50 条
  • [41] Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
    Freedman, Mark S.
    Gnanapavan, Sharmilee
    Booth, Ronald A.
    Calabresi, Peter A.
    Khalil, Michael
    Kuhle, Jens
    Lycke, Jan
    Olsson, Tomas
    EBIOMEDICINE, 2024, 101
  • [42] Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis?
    Sperandei, Silvia
    Menculini, Giulia
    Gaetani, Lorenzo
    Cinesi, Gianmarco
    Di Sabatino, Elena
    Tortorella, Alfonso
    Parnetti, Lucilla
    Di Filippo, Massimiliano
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 964 - 965
  • [43] Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis
    Mollgaard, M.
    Degn, M.
    Sellebjerg, F.
    Frederiksen, J. L.
    Modvig, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (05) : 898 - 905
  • [44] Correlation of neurofilament light (NfL) chain levels with cognitive assessment in multiple sclerosis (MS)
    Aktas, O.
    Filser, M.
    Huss, A.
    Renner, A.
    Baetge, S.
    Stute, N.
    Gasis, M.
    Lepka, K.
    Goebels, N.
    Senel, M.
    Graf, J.
    Hartung, H. -P.
    Albrecht, P.
    Otto, M.
    Tumani, H.
    Penner, I. -K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 723 - 724
  • [45] Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia
    Ma, Weibin
    Zhang, Jingjing
    Xu, Jialei
    Feng, Depeng
    Wang, Xiaoling
    Zhang, Fengyu
    DISEASE MARKERS, 2020, 2020
  • [46] Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis
    Toscano, Simona
    Oteri, Vittorio
    Chisari, Clara Grazia
    Finocchiaro, Chiara
    Lo Fermo, Salvatore
    Valentino, Paola
    Bertolotto, Antonio
    Zappia, Mario
    Patti, Francesco
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 80
  • [47] Cognitive Impairment Is Related to Cerebrospinal Fluid Neurofilament Levels in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis. A Functional MRI Study
    Tortorella, Carla
    Romano, Raffaella
    Ruggieri, Maddalena
    Direnzo, Vita
    Mastrapasqua, Mariangela
    Iaffaldano, Pietro
    Taurisano, Paolo
    Fazio, Leonardo
    Luciannatelli, Elena
    Popolizio, Teresa
    Blasi, Giuseppe
    Bertolino, Alessandro
    Trojano, Maria
    NEUROLOGY, 2012, 78
  • [48] Cerebrospinal fluid neurofilament light chain in acute optic neuritis and its predictive ability of multiple sclerosis
    Passali, Moschoula
    Galea, Ian
    Knudsen, Maria Hojberg
    Lau, Laurie Chi
    Cramer, Stig Praestekjaer
    Frederiksen, Jette Lautrup
    JOURNAL OF NEUROLOGY, 2024, : 6127 - 6135
  • [49] Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neurons
    Pinteac, Rucsanda
    Soriano, Jordi
    Matute-Blanch, Clara
    Lizcano, Jose M.
    Duarri, Anna
    Malhotra, Sunny
    Eixarch, Herena
    Comellas, Gloria Lopez
    Montalban, Xavier
    Comabella, Manuel
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (12):
  • [50] Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
    Jakimovski, Dejan
    Bergsland, Niels
    Dwyer, Michael G.
    Ramasamy, Deepa P.
    Ramanathan, Murali
    Weinstock-Guttman, Bianca
    Zivadinov, Robert
    DIAGNOSTICS, 2020, 10 (09)